CN116253771A - 人参皂苷衍生物及其制备方法与其抗炎应用 - Google Patents
人参皂苷衍生物及其制备方法与其抗炎应用 Download PDFInfo
- Publication number
- CN116253771A CN116253771A CN202310056272.2A CN202310056272A CN116253771A CN 116253771 A CN116253771 A CN 116253771A CN 202310056272 A CN202310056272 A CN 202310056272A CN 116253771 A CN116253771 A CN 116253771A
- Authority
- CN
- China
- Prior art keywords
- dihydroxy
- formula
- damantan
- beta
- ginsenoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310056272.2A CN116253771A (zh) | 2023-01-17 | 2023-01-17 | 人参皂苷衍生物及其制备方法与其抗炎应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310056272.2A CN116253771A (zh) | 2023-01-17 | 2023-01-17 | 人参皂苷衍生物及其制备方法与其抗炎应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116253771A true CN116253771A (zh) | 2023-06-13 |
Family
ID=86681994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310056272.2A Pending CN116253771A (zh) | 2023-01-17 | 2023-01-17 | 人参皂苷衍生物及其制备方法与其抗炎应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116253771A (zh) |
-
2023
- 2023-01-17 CN CN202310056272.2A patent/CN116253771A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107213466B (zh) | 一种柱芳烃类复合物、其制备方法、药物组合物和用途 | |
CN102397269B (zh) | 查尔酮类化合物在制备抗炎药物中的应用 | |
CN111233649A (zh) | 一种抗新型冠状病毒的萘醌类化合物及其医药用途 | |
Deng et al. | Synthesis and discovery of new compounds bearing coumarin scaffold for the treatment of pulmonary fibrosis | |
CN105646611B (zh) | 一种二咖啡酰亚精胺衍生物糖苷及其用途 | |
WO2018086242A1 (zh) | pH敏感的轴向取代硅酞菁配合物及其制备方法和在医药上的应用 | |
CN100572374C (zh) | 葛根素衍生物及其医学用途 | |
CN111410643B (zh) | 一种新的肉桂酰酯儿茶素及四种新的苯丙素黄烷生物碱制备和应用 | |
WO2021244051A1 (zh) | 一种11-o-罗汉果醇肟醚衍生物及其制备方法 | |
CN110283166B (zh) | 乙氧基桥连的噻唑香豆素类化合物及其制备方法和应用 | |
CN116253771A (zh) | 人参皂苷衍生物及其制备方法与其抗炎应用 | |
JP2008506722A (ja) | シス−1,2−置換スチルベン誘導体、および糖尿病の治療および/または予防のための薬剤の製造におけるそれらの使用 | |
CN102336790B (zh) | 一氧化氮供体型虎杖苷衍生物、制备方法及医药用途 | |
BRPI0806461B1 (pt) | monossal do ácido maleico, e, composição farmacêutica para a prevenção ou tratamento das infecções virais | |
CN104945455B (zh) | 香豆素苷类化合物、其制法和药物组合物与用途 | |
CN110590779B (zh) | 3,10二对氯苯基6,12二氮杂四高立方烷类化合物及其合成方法、应用和药物组合物 | |
CN111647036B (zh) | 一类Ocotillol型酯化衍生物及其制备方法和制作抗炎药物的用途 | |
CN108129543A (zh) | 一种齐墩果酸衍生物及其制备方法和应用 | |
CN111825608A (zh) | 四氢喹啉类与四氢异喹啉类化合物及其用途 | |
EP0448029A2 (en) | Novel pharmaceutical uses of forskolin derivatives | |
JPH0678231B2 (ja) | 血液粘度低下剤 | |
CN116730919A (zh) | 一种二萜生物碱型化合物及其提取方法和应用 | |
US20070155830A1 (en) | Concentricolide and its derivatives, process for preparing them, pharmaceutical composition comprising the same and its use | |
CN114181179B (zh) | 一种含萘醌肟结构的化合物及其作为蛙皮素受体亚型-3激动剂的医药用途 | |
CN112778201B (zh) | 一种苯并[b]氮杂䓬-查尔酮杂合物及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB03 | Change of inventor or designer information |
Inventor after: Yang Gangqiang Inventor after: Mi Xiaoliang Inventor after: Li Shuang Inventor after: Wang Yunxiao Inventor after: Yu Liping Inventor after: Tan Shuai Inventor after: Huang Xinru Inventor after: Yang Xiaoyue Inventor after: Luan Xuwen Inventor before: Yang Gangqiang Inventor before: Mi Xiaoliang Inventor before: Li Shuang Inventor before: Wang Yunxiao Inventor before: Yu Liping Inventor before: Tan Shuai Inventor before: Huang Xinru Inventor before: Yang Xiaoyue Inventor before: Luan Xuwen |
|
CB03 | Change of inventor or designer information | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |